Study Summary
This trial is testing a new way to help people with chronic liver disease who have unhealthy alcohol use. The new treatment includes 3 sessions of motivational interviewing, and referral to addiction medicine if necessary. The trial will measure how well the new treatment works at 6 and 12 months.
- Alcoholism
- Liver Disease
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 6 months after enrollment
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Usual Care (UC)
1 of 2
Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use
1 of 2
Active Control
Experimental Treatment
180 Total Participants · 2 Treatment Groups
Primary Treatment: Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the current enrollment of participants in this trial?
"Affirmative. Information on clinicaltrials.gov indicates that this medical trial is still recruiting participants, with initial postings occurring February 1st 2022 and the most recent update being April 25th 2022. 180 patients are needed between two health care facilities." - Anonymous Online Contributor
Are there still open spots for this trial that participants can sign up for?
"Affirmative. The clinicaltrials.gov page indicates that this research trial is actively recruiting individuals as of April 25th, 2022. It was first posted on February 1st and requires 180 participants from 2 sites to complete the study." - Anonymous Online Contributor